Literature DB >> 18155964

Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly.

Ivan K Chinn1, Blythe H Devlin, Yi-Ju Li, M Louise Markert.   

Abstract

Thymus transplantation in subjects with complete DiGeorge anomaly using postnatal allogeneic HLA-nonmatched cultured thymus tissue provides immunoreconstitution. Tolerance of the newly developed T cells toward the donor thymus has not previously been studied. Mixed lymphocyte cultures were used to test 12 thymus transplant recipients for long-term tolerance toward their thymus allografts. Two subjects tested for responses toward thymus donor peripheral blood mononuclear cells showed significantly less reactivity toward the donors compared to responses against third-party allogeneic cells. Peripheral blood mononuclear cells from 10 other subjects were less responsive toward cryopreserved donor thymic cells than toward allogeneic cells (P=0.00007). Adult control peripheral blood mononuclear cells proliferated strongly in response to the donor thymic cells. Both the subjects and controls showed similar proliferative responses against allogeneic cells and phytohemagglutinin. This study provides in vitro evidence for long-term tolerance of complete DiGeorge anomaly thymus transplantation recipients toward their HLA-nonmatched thymus grafts.

Entities:  

Mesh:

Year:  2007        PMID: 18155964      PMCID: PMC2562745          DOI: 10.1016/j.clim.2007.11.009

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  Lymphocytes which differentiate in an allogeneic thymus. II. Evidence for both central and peripheral mechanisms in tolerance to donor strain tissues.

Authors:  B Kindred; B Sordat
Journal:  Eur J Immunol       Date:  1977-07       Impact factor: 5.532

Review 2.  The molecular basis of allorecognition.

Authors:  L A Sherman; S Chattopadhyay
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

3.  Transplantation of cultured thymus fragments. III. Induction of allotolerance.

Authors:  R Hong; R Klopp
Journal:  Thymus       Date:  1982-02

4.  Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients.

Authors:  M Louise Markert; Marcella Sarzotti; Daniel A Ozaki; Gregory D Sempowski; Maria E Rhein; Laura P Hale; Francoise Le Deist; Marilyn J Alexieff; Jie Li; Elizabeth R Hauser; Barton F Haynes; Henry E Rice; Michael A Skinner; Samuel M Mahaffey; James Jaggers; Leonard D Stein; Michael R Mill
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

Review 5.  The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome.

Authors:  W Müller; H H Peter; M Wilken; H Jüppner; H C Kallfelz; H P Krohn; K Miller; C H Rieger
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

6.  Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases.

Authors:  M Louise Markert; Marilyn J Alexieff; Jie Li; Marcella Sarzotti; Daniel A Ozaki; Blythe H Devlin; Gregory D Sempowski; Maria E Rhein; Paul Szabolcs; Laura P Hale; Rebecca H Buckley; Katharine E Coyne; Henry E Rice; Samuel M Mahaffey; Michael A Skinner
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

7.  Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome.

Authors:  M Louise Markert; Marilyn J Alexieff; Jie Li; Marcella Sarzotti; Daniel A Ozaki; Blythe H Devlin; Debra A Sedlak; Gregory D Sempowski; Laura P Hale; Henry E Rice; Samuel M Mahaffey; Michael A Skinner
Journal:  Blood       Date:  2004-04-20       Impact factor: 22.113

Review 8.  The DiGeorge anomaly.

Authors:  R Hong
Journal:  Immunodefic Rev       Date:  1991

9.  Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants.

Authors:  M Louise Markert; Blythe H Devlin; Marilyn J Alexieff; Jie Li; Elizabeth A McCarthy; Stephanie E Gupton; Ivan K Chinn; Laura P Hale; Thomas B Kepler; Min He; Marcella Sarzotti; Michael A Skinner; Henry E Rice; Jeffrey C Hoehner
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

10.  The spectrum of the DiGeorge syndrome.

Authors:  M E Conley; J B Beckwith; J F Mancer; L Tenckhoff
Journal:  J Pediatr       Date:  1979-06       Impact factor: 4.406

View more
  9 in total

Review 1.  Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly.

Authors:  Ivan K Chinn; M Louise Markert
Journal:  J Allergy Clin Immunol       Date:  2011-04-21       Impact factor: 10.793

2.  Immunologic reconstitution in 22q deletion (DiGeorge) syndrome.

Authors:  Sean A McGhee; Maria Garcia Lloret; E Richard Stiehm
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 3.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

4.  Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation.

Authors:  Ivan K Chinn; John A Olson; Michael A Skinner; Elizabeth A McCarthy; Stephanie E Gupton; Dong-Feng Chen; Francisco A Bonilla; Robert L Roberts; Maria G Kanariou; Blythe H Devlin; M Louise Markert
Journal:  J Allergy Clin Immunol       Date:  2010-09-15       Impact factor: 10.793

Review 5.  The role of the thymus in tolerance.

Authors:  Adam D Griesemer; Eric C Sorenson; Mark A Hardy
Journal:  Transplantation       Date:  2010-09-15       Impact factor: 4.939

6.  Cultured thymus tissue implantation promotes donor-specific tolerance to allogeneic heart transplants.

Authors:  Jean Kwun; Jie Li; Clay Rouse; Jae Berm Park; Alton B Farris; Maragatha Kuchibhatla; Joseph W Turek; Stuart J Knechtle; Allan D Kirk; M Louise Markert
Journal:  JCI Insight       Date:  2020-06-04

Review 7.  Inborn errors of thymic stromal cell development and function.

Authors:  Alexandra Y Kreins; Stefano Maio; Fatima Dhalla
Journal:  Semin Immunopathol       Date:  2020-11-30       Impact factor: 9.623

Review 8.  Current and Future Therapeutic Approaches for Thymic Stromal Cell Defects.

Authors:  Alexandra Y Kreins; Paola Bonfanti; E Graham Davies
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

Review 9.  Immunodeficiency in DiGeorge Syndrome and Options for Treating Cases with Complete Athymia.

Authors:  E Graham Davies
Journal:  Front Immunol       Date:  2013-10-31       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.